Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who received a kidney transplant from the year 2000 onwards
- People who were diagnosed with a kidney condition called FSGS (focal segmental glomerulosclerosis) or MCD (minimal change disease) in their original kidney, before the transplant took place
Who may not be able to join:
- People whose kidney condition was diagnosed as something other than FSGS or MCD
- People whose FSGS or MCD was caused by another underlying condition, such as lupus, IgA nephropathy, or cancer
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Eloise Salmon, MD, University of Michigan
Phone: 734-647-5446
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Time to FSGS Recurrence; Time to Graft Failure
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.